Genitourinary Cancer,Prostate Cancer Ipatasertib + Abiraterone for mCRPC: Efficacy and Safety Mar 28, 2023
Genitourinary Cancer,Prostate Cancer PSMA and FDG-PET as Biomarkers in mCRPC: Phase 2 Study Mar 28, 2023
Genitourinary Cancer,Prostate Cancer Patient-Reported Outcomes in Advanced Prostate Cancer: Analysis Mar 28, 2023
Genitourinary Cancer,Prostate Cancer APA+ADT Therapy for Metastatic Prostate Cancer: Improved Outcomes Mar 28, 2023
Genitourinary Cancer,Prostate Cancer Comparing ENZA + TALA to Placebo + ENZA in Treating mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer PROs of Pembrolizumab + Olaparib Treatment in Patients with mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer Efficacy and Safety of Pembrolizumab and Docetaxel for mCRPC Mar 27, 2023
Genitourinary Cancer,Prostate Cancer TALA Efficacy vs. Placebo with ENZA in First-Line mCRPC Treatment Mar 27, 2023
